A Scoping Review to Assess Adherence to and Clinical Outcomes of Wearable Devices in the Cancer Population

Yaoru Huang, Umashankar Upadhyay, Eshita Dhar, Li Jen Kuo, Shabbir Syed-Abdul

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

The use of wearable devices (WDs) in healthcare monitoring and management has attracted increasing attention. A major problem is patients’ adherence and acceptance of WDs given that they are already experiencing a disease burden and treatment side effects. This scoping review explored the use of wrist-worn devices in the cancer population, with a special focus on adherence and clinical outcomes. Relevant articles focusing on the use of WDs in cancer care management were retrieved from PubMed, Scopus, and Embase from 1 January 2017 to 3 March 2022. Studies were independently screened and relevant information was extracted. We identified 752 studies, of which 38 met our inclusion criteria. Studies focused on mixed, breast, colorectal, lung, gastric, urothelial, skin, liver, and blood cancers. Adherence to WDs varied from 60% to 100%. The highest adherence was reported in the 12-week studies. Most studies focused on physical activity, sleep analysis, and heart vital signs. Of the 10 studies that described patient-reported outcomes using questionnaires and personal interviews, 8 indicated a positive correlation between the patient-reported and wearable outcomes. The definitions of the outcome measures and adherence varied across the studies. A better understanding of the intervention standards in terms of the clinical outcomes could improve adherence to wearables.

Original languageEnglish
Article number4437
JournalCancers
Volume14
Issue number18
DOIs
Publication statusPublished - Sep 2022

Keywords

  • cancer
  • eHealth
  • health monitoring
  • wearable devices

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'A Scoping Review to Assess Adherence to and Clinical Outcomes of Wearable Devices in the Cancer Population'. Together they form a unique fingerprint.

Cite this